Pink ribbon prevention and control of popular science action carried out throughout the country

BEIJING, Oct. 17 (Reporter Li Yanan) in order to help early diagnosis and treatment, promote breast cancer prevention and treatment, "China Breast Cancer Patient Health Management" pink ribbon prevention and control science and technology action is being carried out throughout the country. National Cancer Center Breast Cancer Screening and Early Treatment Standards
Secretary-General of the Chinese Medical
Cancer Hospital Professor Ma Fei recently called on the majority of female compatriots to care for their own health, regular self-examination, and detailed the risk factors of breast cancer, suitable for Chinese women breast cancer diagnosis methods.
october is International Breast Cancer Care Month. "China Breast Cancer Patient Health Management" pink ribbon prevention and control science action by the National Cancer Quality Control Center breast cancer experts
, China Cancer Foundation, Beijing Breast Cancer Prevention Society, China Health Management Association Health Communication Branch, social welfare organizations, the League of Living People, Hengrui medical support. As a special event that lasts throughout the month, a live broadcast of breast cancer science and technology by well-known breast cancer experts and internet hosts at the United Nations was held in Beijing recently. The live broadcast aims to popularize all-round, full-cycle knowledge of breast cancer prevention and treatment to the general public and patients, and calls on the public to care for breast cancer patients.
, breast cancer is the most common malignant tumor in Chinese women, the incidence of breast cancer in China is 4255/100,000 people, it is expected that by 2021, breast cancer patients will reach 2.5 million. According to statistics, 81.4% of women in China do not know enough about breast cancer disease, the early diagnosis rate of breast cancer is less than 30%, many women have missed the best time to treat breast cancer when diagnosed. Although the five-year survival rate of breast cancer patients in China has increased to 83.2%, there is still a gap compared with developed countries. Low detection rates early are one of the important reasons. In particular, HER2-positive breast cancer, which has the highest recurrence and mortality rates of all breast cancer groups, requires more attention.
Professor Ma Fei said in the live broadcast: "In accordance with the 'Healthy China 2030' national strategy deployment, to complete the task of increasing the five-year survival rate of cancer by 15% by 2030, it is necessary to move the cancer prevention and treatment level forward, to do a good job of early detection, early diagnosis and early treatment of people at high risk of breast cancer." At the same time, for healthy people to do a good job of education, reduce the incidence of disease, to achieve effective prevention. He called on women to care for their own health, regular self-examination, and detailed the risk factors of breast cancer, suitable for Chinese women's breast cancer diagnosis methods, breast cancer patients throughout the multidisciplinary comprehensive treatment and rehabilitation period of all-round, interdisciplinary health management and other breast cancer prevention and treatment knowledge.Professor Ma Fei said:
"In the International Breast Cancer Care Month to host the "China Breast Cancer Patient Health Management" pink ribbon prevention and control science action, is to practice the 'all-round promotion, full cycle promotion' of breast cancer health management concept, from breast cancer prevention, diagnosis, treatment, rehabilitation and other links, for the vast number of female compatriots and patients to carry out systematic breast cancer disease science education." In recent years, with the continuous improvement of global medical technology, the clinical treatment options for patients with advanced breast cancer, especially HER2-positive breast cancer, have become more and more abundant. In addition to international imports of targeted drugs, China's domestic original research oral targeted drugs have also been proved in many clinical studies can make HER2-positive breast cancer patients benefit, HER2-positive advanced breast cancer to achieve long-term survival and even clinical cure at hand. Not only that, more and more perfect patients' whole course management mode has promoted the survival benefit of patients with advanced breast cancer in China, and greatly improved the quality and life cycle of patients. It is hoped that through this popular science action, patients will be more aware of and confident in scientific response to diseases and work together to improve the cure rate. Liu
, chairman of the Alliance of Activists, the organiser of the event, said breast cancer patients should not only live long, but also live well. Improved lifestyle and appropriate psychological intervention can effectively reduce the risk of death and recurrence of breast cancer patients and improve the quality of life. The month-long topics covered include breast health care and breast cancer prevention, image management and psychosocial psychology of breast cancer patients, long-term symptom management during breast cancer treatment, and diet and exercise for breast cancer patients.
as of October 16, "All-out efforts to live a happy life" "China's breast cancer patient health management" pink ribbon prevention and control science action has been held in Xi'an, Liaoning, Guangxi, Huaihua, Zhuzhou and other places. In the next International Breast Cancer Care Month, there will be nearly 30 online and offline linked breast cancer prevention and popular science activities in all provinces and cities across the country. (Complete)